-
From Denise Croix on February 15th, 2021
0 likes 0 playsDr. Beatrice Wegrzyniak of Roche medical and scientific affairs provides an overview of interpretation of the CINtec PLUS Cytology Assay for cervical cancer triage. … -
From Denise Croix on February 15th, 2021
0 likes 2 playsDr. Beatrice Wegrzyniak of Roche medical and scientific affairs team discusses the biomarkers that indicate cell cycle deregulation in cervical cancer screening. Part… -
From Denise Croix on February 15th, 2021
0 likes 1 playsDr. Linda Ahn from Roche Medical and Scientific Affairs team provides an introduction to the IMPACT trial data for use of biomarkers in cervical cancer triage. Part 2… -
From Denise Croix on February 15th, 2021
0 likes 2 playsDr. Linda Ahn from Roche Medical and Scientific Affairs team discusses the current standard of care in cervical cancer screening. Part 1 of a 4 part series. Content… -
From Bharathi Vennapusa on January 31st, 2021
1 likes 3 playsDrs. Bharathi Vennapusa, Denise Croix and Katie Robertson discuss overview of NTRK fusions, testing methods, algorithms with a focus on pan-TRK IHC assay using VENTANA… -
From Bharathi Vennapusa on January 29th, 2021
0 likes 0 playsIn this short video, Roche Pathologist, Michael Lynch, M.D. reviews the scoring method for the VENTANA HER2 Dual ISH assay as well as discusses scoring challenges and… -
From Bharathi Vennapusa on January 14th, 2021
0 likes 5 playsRecording for Dr. Lawrence Weiss's talk on CAP Today Webinar from December 1, 2020. Title: Tracking TRK with IHC: Today’s Diagnostic Algorithms for NTRK… -
From Bharathi Vennapusa on December 4th, 2020
0 likes 2 playsBrief video on scoring algorithm for VENTANA HER2 Dual ISH DNA Probe Cocktail. Content and approvals of any product related information is current as of the date of… -
From Bharathi Vennapusa on December 2nd, 2020
0 likes 3 playsThis video is an explainer of the recent relaxation of FDA and CMS guidance on digital pathology during the COVID19 pandemic. Roche Medical and Scientific Affairs… -
From Bharathi Vennapusa on December 2nd, 2020
0 likes 4 playsUS Medical and Scientific Affairs (MSA) pathologist Dr. Erin Marner provides an overview of the PD-L1 (SP263) Assay by reviewing two urothelial carcinoma cases. Common… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsDr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the borderline tissue staining of IC around 1% of tumor area that a… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsDr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common pattern of tissue staining a pathologist will see in… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 2 playsDr. Michael Lynch of Medical and Scientific Affairs for Roche Diagnostics reviews 3 cases that show the most common tissue staining pattern a pathologist will see in the… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 1 playsVENTANA PD-L1 (SP142) assay is the first and only FDA-approved assay for mTNBC*. Testing for PD-L1 identifies patients who could benefit from TECENTRIQ + nab-pac in… -
From Bharathi Vennapusa on November 22nd, 2020
0 likes 3 playsVENTANA PD-L1 (SP142) IHC assay is FDA-approved for mTNBC. Test for PD-L1 to identify patients who could benefit from TECENTRIQ + nab-pac in 1L mTNBC* This video is…
Search for ""
Public, Open and Moderated
- Managers:
- Appears in: